Micro-fiber webs of poly-4-hydroxybutyrate and copolymers thereof produced by centrifugal spinning

Patent metadata

Field	Value
Publication number	US-9457127-B2
Application number	US-201514661172-A
Country	US
Kind code	B2
Filing date	Mar 18, 2015
Priority date	Mar 18, 2014
Publication date	Oct 4, 2016
Grant date	Oct 4, 2016

Abstract

Methods to produce micro-fiber webs containing fibers of 4-hydroxybutyrate or copolymers thereof with average diameters from 0.01 to 100 μm, have been developed. The micro-fiber webs are produced by centrifugal spinning. These methods allow the micro-fiber webs to be produced without substantial loss of the polymer weight average molecular weight. Webs containing micro-fibers of poly-4-hydroxybutyrate or copolymer thereof, are made by centrifugal spinning. The micro-fibers have average diameters ranging from 0.01 to 100 μm and contain crimped fibers with a higher elongation at break fibers when compared to fibers derived by melt-blown extrusion, dry spinning and electrospinning. The fibers of the micro-fiber webs have a high degree of orientation. These micro-fiber webs can be used for a variety of purposes including fabrication of medical devices.

First claim

We claim:

1. A micro-fiber web comprising fibers of poly-4-hydroxybutyrate or copolymer thereof, produced by centrifugal spinning, wherein the micro-fiber web has an elongation to break greater than 210%.

2. The micro-fiber web of claim 1 wherein some or all of the fibers are crimped.

3. The micro-fiber web of claim 1 wherein the weight average molecular weight of the poly-4-hydroxybutyrate or copolymer thereof is greater than 50 kDa relative to polystyrene.

4. The micro-fiber web of claim 1 further comprising fibers of a second material or comprising fibers of a blend of poly-4-hydroxybutyrate or copolymer thereof with a second material.

5. The micro-fiber web of claim 4 wherein the second material consists of proteins, polysaccharides, synthetic polymers, or polymers derived from glycolic acid, glycolid, lactic acid, lactide, 1,4-dioxanone, trimethylene carbonate and caprolactone.

6. The micro-fiber webs of claim 1 wherein the average diameter of the fibers is between 0.01 to 100 microns.

7. The micro-fiber webs of claim 1 wherein the centrifugal spun fibers have been deposited on a P4HB monofilament mesh, a P4HB multifilament mesh, a P4HB nonwoven fabric, a P4HB woven fabric, a P4HB foam, or a P4HB film.

8. The micro-fiber webs of claim 1 further comprising an additive wherein the additives are plasticizers, nucleants, compatibilizers, porogens, radiolabelled substances, imaging agents, radiopaque markers, contrast agents, dyes, and bioactive agents.

9. The micro-fiber webs of claim 7 wherein the micro-fiber web is formed into a medical device.

10. The micro-fiber webs of claim 9 wherein the micro-fiber web is formed into a wound dressing.

11. The device of claim 9 wherein the device is used for the repair, regeneration, remodeling or replacement of soft or hard tissue.

12. The device of claim 11 selected from the group consisting of a stent, stent graft, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, hernia plug, cardiovascular patch, vascular closure device, sling, rotator cuff repair device, meniscus repair device, guided tissue repair/regeneration device, articular cartilage repair device, osteochondral repair device, bone void filler, nerve guide, tendon repair device, intracardiac septal defect repair device, atrial septal defect repair device, patent foramen ovale (PFO) closure device, left atrial appendage (LAA) closure device, pericardial patch, bulking and filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, spinal fusion device, skin substitute, wound healing device, dural substitute, bone graft substitute, wound dressing, ulcer repair device, a hemostat and devices selected from the group consisting of textiles for face lift, neck lift, eyebrow lift, breast lift and breast reconstruction.

13. A method for preparing micro-fiber webs of claim 1 by centrifugal spinning, wherein the method comprises:
(a) preparing a spinning solution comprising poly-4-hydroxybutyrate or copolymer thereof by dissolving the polymer or copolymer in an organic solvent;
(b) optionally adding an additive to the spinning solution;
(c) spinning the solution using a centrifugal spinner.

14. The method of claim 13 wherein the micro-fiber web is produced by simultaneously spinning the micro-fiber web comprising poly-4-hydroxybutyrate or copolymer with a second material or as a blend with a second material.

15. The method of claim 13 further comprising coating the micro-fiber web with a radiolabelled substance, imaging agent, radiopaque marker, contrast agent, dye, and bioactive agent.

16. The method of claim 13 wherein the solvent is selected from the group consisting of methylene chloride, chloroform, dichloroethane, tetrachloroethane, trichloroethane, dibromomethane, bromoform, tetrahydrofuran, acetone, acetonitrile, N-methylpyrrolidone, dimethylformamide, dimethylacetamide, dimethylsulfoxide, and 1,4-dioxane, alone, or combined into a mixed solvent.

17. The method of claim 13 wherein the spinning solution or solutions are ejected from one or more spinnerets through a single orifice or a plurality of orifices.

18. The methods of claim 13 wherein the micro-fiber web is formed into a device, and wherein the device is selected from the group consisting of a stent, stent graft, drug delivery device, device for temporary wound or tissue support, device for soft or hard tissue repair or regeneration, repair patch, tissue engineering scaffolds, retention membranes anti-adhesion membrane, tissue separation, membrane, hernia repair device, hernia plug, cardiovascular patch, vascular closure device, sling, rotator cuff repair device, meniscus repair device, guided tissue repair/regeneration device, articular cartilage repair device, osteochondral repair device, bone void filler, nerve guide, tendon repair device, intracardiac septal defect repair device, atrial septal defect repair devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure device, pericardial patch, bulking and filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, spinal fusion device, skin substitute, wound healing device, dural substitute, bone graft substitute, wound dressing, ulcer repair device, a hemostat and devices selected from the group consisting of textiles for face lift, neck lift, eyebrow lift, breast lift and breast reconstruction.

19. A method of using the device of claim 9 wherein the device is implanted in the body or applied topically to the surface of the body.

Assignees

• Tepha Inc

Inventors

• Martin David P
• Rizk Said

Classifications

• A61L31/041

  Mixtures of macromolecular compounds · CPC title

• A61L2420/02

  Methods for coating medical devices · CPC title

• A61F13/00017

  Human Necessities · mapped topic

• D01F6/625

  derived from hydroxy-carboxylic acids, e.g. lactones · CPC title

• A61L15/42

  Use of materials characterised by their function or physical properties (liquid bandages A61L26/00) · CPC title